Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jun
17
2015
Federal Circuit Invalidates Sequenom’s Fetal DNA Prenatal Diagnosis Patent as Not Patent Eligible Barnes & Thornburg LLP
Sep
25
2019
The FLSA Protects Colorado’s Recreational Cannabis Workers Barnes & Thornburg LLP
Aug
13
2015
New York Federal Court Authorizes Pharmaceutical Firm to Engage in Off-label Promotion Using Certain Specific Information and Statements Alert Barnes & Thornburg LLP
Oct
7
2019
U.S. Set To Impose Retaliatory Tariffs On $7.5 Billion In EU Goods Following WTO’s Airbus Ruling Barnes & Thornburg LLP
Jan
13
2016
What You May Not Know (But Should) About Voluntarily Surrendering Your DEA Registration Barnes & Thornburg LLP
Jan
20
2016
FDA Issues Draft Guidance on Cybersecurity for Medical Devices Barnes & Thornburg LLP
Feb
26
2020
FDA Issues More Guidance On Intentional Adulteration Of Food Rule Barnes & Thornburg LLP
Jun
29
2023
Nonimmigrant Travelers Can Now Board Flights to U.S. Without Proof of COVID-19 Vaccination Barnes & Thornburg LLP
May
31
2016
FDA Addresses Postmarket Surveillance For Medical Devices In Final Guidance Barnes & Thornburg LLP
Nov
18
2016
Updated, Expanded Guidance Issued for Food Facility Registration Barnes & Thornburg LLP
Oct
30
2017
New Guidance for Medical Device Industry, FDA Staff on 510(k) Submissions for Changes to Existing Devices Barnes & Thornburg LLP
Jan
23
2018
New Guidance Details FDA’s Intent to Use Discretion for Enforcing Portions of Food Safety Modernization Act Barnes & Thornburg LLP
Apr
20
2018
FDA to Expand Abbreviated 510(k) Pathway for Medical Devices by Allowing Comparison to Performance Criteria Barnes & Thornburg LLP
Sep
25
2013
EPA Proposes Rule to Cap Carbon Emissions from New Power Plants Barnes & Thornburg LLP
Jan
4
2019
CBD Use in the Workplace: Resolving State And Federal Law Conflicts Barnes & Thornburg LLP
Aug
21
2014
FDA Says “Fuhgeddaboudit” To Its Own Proposed Pre-Decisional IDE Process Barnes & Thornburg LLP
Jul
17
2019
FDA Issues Final Rule On Appeals Of Medical Device Decisions Barnes & Thornburg LLP
Nov
17
2015
FDA Publishes Final Rule on Accreditation of Third-Party Certification Bodies to Conduct Food Safety Audits Barnes & Thornburg LLP
Nov
22
2019
Mexico Creates Warning Label Requirements For Certain Foods, Beverages Sold In Mexico Barnes & Thornburg LLP
Dec
9
2015
FDA Issues Draft Guidance on Voluntary Labeling of GMO Foods Barnes & Thornburg LLP
May
28
2023
New Consumer Product Safety Regulations In The EU Barnes & Thornburg LLP
Apr
7
2016
FDA Issues Final Rule on Sanitary Transportation of Food Barnes & Thornburg LLP
Oct
11
2016
FDA Finalized Guidance on Including Patient Preference Information in Certain Medical Device Pre-Market Submissions Barnes & Thornburg LLP
Dec
13
2016
Major FDA Reform Bill Becomes Law: Medical Device Overview Barnes & Thornburg LLP
Jan
30
2017
New Jersey Supreme Court Deals Blow to Drug and Device Manufactures Seeking to Avoid Forum Shopping Barnes & Thornburg LLP
Jul
6
2017
State Budget Update: Impact on Ohio’s Opioid Crisis Barnes & Thornburg LLP
Nov
3
2017
FDA’s Final Guidance Restricts Sharing Patient-Specific Information Barnes & Thornburg LLP
Aug
2
2013
Federal District Courts Request FDA to Define “Natural” With Respect to Genetically-Modified Organisms (GMO) Foods Barnes & Thornburg LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins